University of Colorado Cancer Center


 

Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Untreated Patients, Improvemens & Expansions, Predicting Non-responders

75 views
May 27, 2021
Comments 0
Login to view comments. Click here to Login